'Horrible': JPMorgan Chase Receives Pushback On Biotech Conference Restrictions
December 28, 2017 at 14:18 PM EST
JPMorgan Chase & Co. (NYSE: JPM) is taking heat from investors, reporters and biotech enthusiasts this week after the company ...